Ivan Borbath

5PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 02, 2026
Pembrolizumab Monotherapy in Sorafenib-Treated and Treatment-Naïve Advanced Hepatocellular Carcinoma: Long-Term Follow-up of the Open-Label, Phase II KEYNOTE-224 Study.

Richard S Finn, Masatoshi Kudo, Ivan Borbath

|Jan 31, 2025
Management of high-grade neuroendocrine neoplasms: impact of functional imaging.

O Islam, K Sarti, L Verbruggen

|Mar 02, 2022
ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors.

Ivan Borbath, Ulrich-Frank Pape, Pierre H Deprez

|Jun 26, 2020
Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF 301 trial.

Shalini Makawita, Ghassan K Abou-Alfa, Sameek Roychowdhury

Pageof 1